Traws Pharma Stock (NASDAQ:TRAW)

Revenue Ownership Financials Chart

Previous Close

$4.92

52W Range

$4.44 - $27.50

50D Avg

$5.84

200D Avg

$12.73

Market Cap

$14.22M

Avg Vol (3M)

$10.61K

Beta

1.41

Div Yield

-

TRAW Company Profile

Industry

-

Sector

-

Exchange

NASDAQ

ADR

-

Country

-

Employees

17

IPO Date

-

Website

-

TRAW Performance

TRAW Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$226.00K	$226.00K	$226.00K
Operating Income	$-20.30M	$-19.63M	$-16.50M
Net Income	$-18.95M	$-18.96M	$-16.16M
EBITDA	$-20.28M	$-19.61M	$-16.80M
Basic EPS	$-0.90	$-0.91	$-0.96
Diluted EPS	$-0.90	$-0.91	$-0.96

Fiscal year ends in Dec 23 | Currency in USD